These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 25681712

  • 1. Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors.
    Baharloo F, Moslemin MH, Nadri H, Asadipour A, Mahdavi M, Emami S, Firoozpour L, Mohebat R, Shafiee A, Foroumadi A.
    Eur J Med Chem; 2015 Mar 26; 93():196-201. PubMed ID: 25681712
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors.
    Mostofi M, Mohammadi Ziarani G, Mahdavi M, Moradi A, Nadri H, Emami S, Alinezhad H, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2015 Oct 20; 103():361-9. PubMed ID: 26363872
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and anticholinesterase activity of a novel series of 1-benzyl-4-((6-alkoxy-3-oxobenzofuran-2(3H)-ylidene) methyl) pyridinium derivatives.
    Nadri H, Pirali-Hamedani M, Shekarchi M, Abdollahi M, Sheibani V, Amanlou M, Shafiee A, Foroumadi A.
    Bioorg Med Chem; 2010 Sep 01; 18(17):6360-6. PubMed ID: 20673725
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and Evaluation of Chroman-4-One Linked to N-Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors.
    Arab S, Sadat-Ebrahimi SE, Mohammadi-Khanaposhtani M, Moradi A, Nadri H, Mahdavi M, Moghimi S, Asadi M, Firoozpour L, Pirali-Hamedani M, Shafiee A, Foroumadi A.
    Arch Pharm (Weinheim); 2015 Sep 01; 348(9):643-9. PubMed ID: 26192069
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and cholinesterase inhibitory activity of new 2-benzofuran carboxamide-benzylpyridinum salts.
    Abedinifar F, Farnia SMF, Mahdavi M, Nadri H, Moradi A, Ghasemi JB, Küçükkılınç TT, Firoozpour L, Foroumadi A.
    Bioorg Chem; 2018 Oct 01; 80():180-188. PubMed ID: 29929079
    [Abstract] [Full Text] [Related]

  • 6. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents.
    Saeedi M, Golipoor M, Mahdavi M, Moradi A, Nadri H, Emami S, Foroumadi A, Shafiee A.
    Arch Pharm (Weinheim); 2016 Apr 01; 349(4):293-301. PubMed ID: 26898241
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S, Bayraktar G, Tarikogullari AH, Alptüzün V, Erciyas E.
    Chem Pharm Bull (Tokyo); 2016 Apr 01; 64(9):1281-7. PubMed ID: 27581632
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors.
    Wang C, Wu Z, Cai H, Xu S, Liu J, Jiang J, Yao H, Wu X, Xu J.
    Bioorg Med Chem Lett; 2015 Nov 15; 25(22):5212-6. PubMed ID: 26454504
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, molecular modeling and anticholinesterase activity of benzylidene-benzofuran-3-ones containing cyclic amine side chain.
    Mehrabi F, Pourshojaei Y, Moradi A, Sharifzadeh M, Khosravani L, Sabourian R, Rahmani-Nezhad S, Mohammadi-Khanaposhtani M, Mahdavi M, Asadipour A, Rahimi HR, Moghimi S, Foroumadi A.
    Future Med Chem; 2017 May 15; 9(7):659-671. PubMed ID: 28485614
    [Abstract] [Full Text] [Related]

  • 10. Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling.
    Akrami H, Mirjalili BF, Khoobi M, Nadri H, Moradi A, Sakhteman A, Emami S, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2014 Sep 12; 84():375-81. PubMed ID: 25036795
    [Abstract] [Full Text] [Related]

  • 11. New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study.
    Mollazadeh M, Mohammadi-Khanaposhtani M, Zonouzi A, Nadri H, Najafi Z, Larijani B, Mahdavi M.
    Bioorg Chem; 2019 Jun 12; 87():506-515. PubMed ID: 30928873
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS, Zhang T, Liu Y, Yang J, Xie SS, Liu J, Miao ZY, Ding Y.
    Eur J Med Chem; 2017 Jun 16; 133():184-196. PubMed ID: 28388521
    [Abstract] [Full Text] [Related]

  • 13. Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine "bio-oxidizable" prodrugs: Synthesis, biological evaluation and structure-activity relationship.
    Azzouz R, Peauger L, Gembus V, Ţînţaş ML, Sopková-de Oliveira Santos J, Papamicaël C, Levacher V.
    Eur J Med Chem; 2018 Feb 10; 145():165-190. PubMed ID: 29324339
    [Abstract] [Full Text] [Related]

  • 14. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    Luo XT, Wang CM, Liu Y, Huang ZG.
    Eur J Med Chem; 2015 Oct 20; 103():302-11. PubMed ID: 26363866
    [Abstract] [Full Text] [Related]

  • 15. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F, Karimpour-Razkenari E, Sameem B, Saeedi M, Firuzi O, Edraki N, Mahdavi M, Akbarzadeh T.
    Bioorg Chem; 2019 Nov 20; 92():103192. PubMed ID: 31446239
    [Abstract] [Full Text] [Related]

  • 16. Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
    Kurt BZ, Gazioglu I, Basile L, Sonmez F, Ginex T, Kucukislamoglu M, Guccione S.
    Eur J Med Chem; 2015 Sep 18; 102():80-92. PubMed ID: 26244990
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of new N-benzylpyridinium-based benzoheterocycles as potential anti-Alzheimer's agents.
    Salehi N, Mirjalili BBF, Nadri H, Abdolahi Z, Forootanfar H, Samzadeh-Kermani A, Küçükkılınç TT, Ayazgok B, Emami S, Haririan I, Sharifzadeh M, Foroumadi A, Khoobi M.
    Bioorg Chem; 2019 Mar 18; 83():559-568. PubMed ID: 30471578
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and anti-acetylcholinesterase activity of scopoletin derivatives.
    Khunnawutmanotham N, Chimnoi N, Saparpakorn P, Techasakul S.
    Bioorg Chem; 2016 Apr 18; 65():137-45. PubMed ID: 26943478
    [Abstract] [Full Text] [Related]

  • 19. Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives.
    Chakravarty H, Ju Y, Chen WH, Tam KY.
    Drug Dev Res; 2020 Apr 18; 81(2):242-255. PubMed ID: 31837041
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and biological evaluation of edaravone derivatives bearing the N-benzyl pyridinium moiety as multifunctional anti-Alzheimer's agents.
    Zondagh LS, Malan SF, Joubert J.
    J Enzyme Inhib Med Chem; 2020 Dec 18; 35(1):1596-1605. PubMed ID: 32779503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.